PULS turns life science ideas into attractive business opportunities

PULS is a life science company with a unique combination of scientists and industrialists who together with innovators are commercializing ideas by providing capital, know-how and committed partnership.

Status ongoing projects

Glactone Pharma

(Immuno-oncology)

 
Exit
Phase II/III
Phase I
Preclinical

Oncorena

(Kidney cancer)

 
Exit
Phase II/III
Phase I
Preclinical

Adenovir Pharma

(Eye infection)

 
Exit
Phase II/III
Phase I
Preclinical

Laccure

(Bacterial vaginosis)

 
Exit
CE mark
Clinical
Preclinical

Trophea

(Skin atrophy)

 
Exit
Phase II/III
Phase I
Preclinical

AcuCort

(Acute allergic reactions)

 
IPO
Bioequiv. study
PK-study
Preclinical

Do not hesitate to contact us

Headquarters

Kullagatan 8,
SE-252 20 Helsingborg, Sweden

Regional office

Sahlgrenska Science Park, Medicinaregatan 8A,
SE-413 46 Gothenburg, Sweden